Case Report
Volume 11 Issue 9 - 2020
Nocturnal Effects of Pilocarpine on Intraocular Pressure: A Case Report Using a Contact Lens Sensor
Kaweh Mansouri1,2*, Kirsten Hoskens1 and Kevin Gillmann1
1Glaucoma Research Center, Monchoisi Clinic, Swiss Visio, Lausanne, Switzerland
2Department of Ophthalmology, University of Colorado School of Medicine, Denver, Colorado, USA
*Corresponding Author: Kaweh Mansouri, Glaucoma Research Center, Monchoisi Clinic, Swiss Visio, Lausanne, Switzerland.
Received: July 27, 2020; Published: August 29, 2020


Background: Pilocarpine is cholinergic agent which acts as a direct muscarinic agonist of the ciliary muscles. It is one of the oldest glaucoma medications but at present, no data are available of its nocturnal effects on intraocular pressure (IOP). This report describes a case of progressive primary open-angle glaucoma (POAG) with nocturnal IOP spikes, where a 24-hour contact lens sensor (CLS) was used before and after the introduction of bedtime pilocarpine.

Case Presentation: We describe the case of a 66-year-old phakic female patient with a long-standing history of advanced POAG. Visual field mean deviation (MD) and retinal nerve fibre layer (RNFL) thickness showed clear disease progression despite persistent in-clinic IOP well within her established target range (< 15 mmHg) on once-daily latanoprost. Both OCT and gonioscopic examination confirmed an open angle. A 24- hour IOP-related monitoring with the CLS was scheduled and confirmed the relative diurnal stability of pressure levels, but showed a marked increase in signal throughout the night and coinciding with the time of sleep (10:00 pm) despite the instillation of latanoprost. Based on this finding, a therapeutic trial of once-daily pilocarpine 2% at bed-time was initiated. After one month, a new 24-hour CLS recording showed similar daytime levels to the previous one, but a considerably more stable recording following the application of pilocarpine drops (9:30 pm) and throughout the nocturnal period. Another recording after 6 months confirmed these findings.

Discussions: This report suggests that once-daily topical pilocarpine may have a nocturnal IOP-lowering effect, as an adjunct to prostaglandin agonists. Furthermore, we believe that once-daily 2% pilocarpine may be a good adjunct in glaucoma patients presenting elevated nocturnal IOP, particularly since common pilocarpine-related adverse events (e.g. brow ache, induced myopia) may be significantly reduced or become less relevant during the sleep period. A prospective study would be necessary to generalise this observation.

Keywords: Glaucoma; Open-Angle; Prostaglandin; Adjunction; Combination; Sleep; IOP; CLS; Telemetry; 24h


  1. Weinreb RN and Khaw PT. “Primary open-angle glaucoma”. Lancet7422 (2004): 1711-1720.
  2. Adams CM., et al. “Glaucoma - Next Generation Therapeutics: Impossible to Possible”. Pharmaceutical Research 2 (2018): 25.
  3. Liu JH., et al. “Comparing diurnal and nocturnal effects of brinzolamide and timolol on intraocular pressure in patients receiving latanoprost monotherapy”. Ophthalmology3 (2009): 449-454.
  4. Liu JH., et al. “Diurnal and nocturnal effects of brimonidine monotherapy on intraocular pressure”. Ophthalmology11 (2010): 2075-2079.
  5. Liu JH., et al. “Comparison of the nocturnal effects of once-daily timolol and latanoprost on intraocular pressure”. American Journal of Ophthalmology3 (2004): 389-395.
  6. Ponticello GS., et al. “Dorzolamide, a 40-year wait. From an oral to a topical carbonic anhydrase inhibitor for the treatment of glaucoma”. Pharmaceutical Biotechnology 11 (1998): 555-574.
  7. Mansouri K and Shaarawy T. “Continuous intraocular pressure monitoring with a wireless ocular telemetry sensor: initial clinical experience in patients with open angle glaucoma”. British Journal of Ophthalmology 5 (2011): 627-629.
  8. Mansouri K and Weinreb RN. “Meeting an unmet need in glaucoma: continuous 24-h monitoring of intraocular pressure”. Expert Review of Medical Devices 3 (2012): 225-231.
  9. Mansouri K., et al. “Efficacy of a contact lens sensor for monitoring 24-h intraocular pressure related patterns”. Plos One5 (2015): e0125530.
  10. Gisler C., et al. “Automated Detection and Quantification of Circadian Eye Blinks Using a Contact Lens Sensor”. Translational Vision Science and Technology 1 (2015): 4.
  11. Mansouri K., et al. “Continuous 24-hour monitoring of intraocular pressure patterns with a contact lens sensor: safety, tolerability, and reproducibility in patients with glaucoma”. Archives of ophthalmology 12 (2012): 1534-1539.
  12. Mottet B., et al. “24-hour intraocular pressure rhythm in young healthy subjects evaluated with continuous monitoring using a contact lens sensor”. JAMA Ophthalmology 12 (2013): 1507-1516.
  13. Mansouri K., et al. “Analysis of continuous 24-hour intraocular pressure patterns in glaucoma”. Investigative Ophthalmology and Visual Science13 (2012): 8050-8056.
  14. Mansouri K., et al. “Effect of glaucoma medications on 24-hour intraocular pressure-related patterns using a contact lens sensor”. Clinical and Experimental Ophthalmology9 (2015): 787-795.
  15. Seibold LK., et al. “The Diurnal and Nocturnal Effects of Pilocarpine on Intraocular Pressure in Patients Receiving Prostaglandin Analog Monotherapy”. Journal of Ocular Pharmacology and Therapeutics 8 (2018): 590-595.
  16. Kwong JM., et al. “The dark phase intraocular pressure elevation and retinal ganglion cell degeneration in a rat model of experimental glaucoma”. Experimental Eye Research 112 (2013): 21-28.
  17. Rekas M., et al. “Assessing Efficacy of Canaloplasty Using Continuous 24-Hour Monitoring of Ocular Dimensional Changes”. Investigative Ophthalmology and Visual Science6 (2016): 2533-2542.
  18. Folgar FA., et al. “Effect of successful and partly successful filtering surgery on the velocity of glaucomatous visual field progression”. Journal of Glaucoma.9 (2012): 615-618.
  19. De Moraes CG., et al. “Association Between 24-Hour Intraocular Pressure Monitored With Contact Lens Sensor and Visual Field Progression in Older Adults With Glaucoma”. JAMA Ophthalmology 7 (2018): 779-785.
  20. Oddone F., et al. “Effects of Topical Bimatoprost 0.01% and Timolol 0.5% on Circadian IOP, Blood Pressure and Perfusion Pressure in Patients with Glaucoma or Ocular Hypertension: A Randomized, Double Masked, Placebo-Controlled Clinical Trial”. Plos One10 (2015): e0140601.
  21. Larsson LI. “Effect on intraocular pressure during 24 hours after repeated administration of the fixed combination of latanoprost 0.005% and timolol 0.5% in patients with ocular hypertension”. Journal of Glaucoma 2 (2001): 109-114.
  22. Bron A. “[The circadian effects of antiglaucomatous drugs]”. Journal Francais D Ophtalmologie 2 (2004): 2S33-2S38.
  23. Shan Fan., et al. “Daytime and Nighttime Effects of Brimonidine on IOP and Aqueous Humor Dynamics in Participants With Ocular Hypertension”. Journal of Glaucoma 5 (2014): 276-281.
  24. Yamagishi-Kimura R., et al. “Interaction Between Pilocarpine and Ripasudil on Intraocular Pressure, Pupil Diameter, and the Aqueous-Outflow Pathway”. Investigative Ophthalmology and Visual Science 5 (2018): 1844-1854.
Citation: Kaweh Mansouri., et al. “Nocturnal Effects of Pilocarpine on Intraocular Pressure: A Case Report Using a Contact Lens Sensor”. EC Ophthalmology 11.9 (2020): 28-33.

PubMed Indexed Article

EC Pharmacology and Toxicology
LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2' and 2,4' vs. 4,4') of Methylene Diphenyl-Diisocyanate.

PMID: 31143884 [PubMed]

PMCID: PMC6536005

EC Pharmacology and Toxicology
Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

PMID: 31565701 [PubMed]

PMCID: PMC6764777

EC Neurology
Differences in Rate of Cognitive Decline and Caregiver Burden between Alzheimer's Disease and Vascular Dementia: a Retrospective Study.

PMID: 27747317 [PubMed]

PMCID: PMC5065347

EC Pharmacology and Toxicology
Will Blockchain Technology Transform Healthcare and Biomedical Sciences?

PMID: 31460519 [PubMed]

PMCID: PMC6711478

EC Pharmacology and Toxicology
Is it a Prime Time for AI-powered Virtual Drug Screening?

PMID: 30215059 [PubMed]

PMCID: PMC6133253

EC Psychology and Psychiatry
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

PMID: 30417173 [PubMed]

PMCID: PMC6226033

EC Anaesthesia
Arrest Under Anesthesia - What was the Culprit? A Case Report.

PMID: 30264037 [PubMed]

PMCID: PMC6155992

EC Orthopaedics
Distraction Implantation. A New Technique in Total Joint Arthroplasty and Direct Skeletal Attachment.

PMID: 30198026 [PubMed]

PMCID: PMC6124505

EC Pulmonology and Respiratory Medicine
Prevalence and factors associated with self-reported chronic obstructive pulmonary disease among adults aged 40-79: the National Health and Nutrition Examination Survey (NHANES) 2007-2012.

PMID: 30294723 [PubMed]

PMCID: PMC6169793

EC Dental Science
Important Dental Fiber-Reinforced Composite Molding Compound Breakthroughs

PMID: 29285526 [PubMed]

PMCID: PMC5743211

EC Microbiology
Prevalence of Intestinal Parasites Among HIV Infected and HIV Uninfected Patients Treated at the 1o De Maio Health Centre in Maputo, Mozambique

PMID: 29911204 [PubMed]

PMCID: PMC5999047

EC Microbiology
Macrophages and the Viral Dissemination Super Highway

PMID: 26949751 [PubMed]

PMCID: PMC4774560

EC Microbiology
The Microbiome, Antibiotics, and Health of the Pediatric Population.

PMID: 27390782 [PubMed]

PMCID: PMC4933318

EC Microbiology
Reactive Oxygen Species in HIV Infection

PMID: 28580453 [PubMed]

PMCID: PMC5450819

EC Microbiology
A Review of the CD4 T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population

PMID: 26280024 [PubMed]

PMCID: PMC4533840

EC Neurology
Identifying Key Symptoms Differentiating Myalgic Encephalomyelitis and Chronic Fatigue Syndrome from Multiple Sclerosis

PMID: 28066845 [PubMed]

PMCID: PMC5214344

EC Pharmacology and Toxicology
Paradigm Shift is the Normal State of Pharmacology

PMID: 28936490 [PubMed]

PMCID: PMC5604476

EC Neurology
Examining those Meeting IOM Criteria Versus IOM Plus Fibromyalgia

PMID: 28713879 [PubMed]

PMCID: PMC5510658

EC Neurology
Unilateral Frontosphenoid Craniosynostosis: Case Report and a Review of the Literature

PMID: 28133641 [PubMed]

PMCID: PMC5267489

EC Ophthalmology
OCT-Angiography for Non-Invasive Monitoring of Neuronal and Vascular Structure in Mouse Retina: Implication for Characterization of Retinal Neurovascular Coupling

PMID: 29333536 [PubMed]

PMCID: PMC5766278

EC Neurology
Longer Duration of Downslope Treadmill Walking Induces Depression of H-Reflexes Measured during Standing and Walking.

PMID: 31032493 [PubMed]

PMCID: PMC6483108

EC Microbiology
Onchocerciasis in Mozambique: An Unknown Condition for Health Professionals.

PMID: 30957099 [PubMed]

PMCID: PMC6448571

EC Nutrition
Food Insecurity among Households with and without Podoconiosis in East and West Gojjam, Ethiopia.

PMID: 30101228 [PubMed]

PMCID: PMC6086333

EC Ophthalmology
REVIEW. +2 to +3 D. Reading Glasses to Prevent Myopia.

PMID: 31080964 [PubMed]

PMCID: PMC6508883

EC Gynaecology
Biomechanical Mapping of the Female Pelvic Floor: Uterine Prolapse Versus Normal Conditions.

PMID: 31093608 [PubMed]

PMCID: PMC6513001

EC Dental Science
Fiber-Reinforced Composites: A Breakthrough in Practical Clinical Applications with Advanced Wear Resistance for Dental Materials.

PMID: 31552397 [PubMed]

PMCID: PMC6758937

EC Microbiology
Neurocysticercosis in Child Bearing Women: An Overlooked Condition in Mozambique and a Potentially Missed Diagnosis in Women Presenting with Eclampsia.

PMID: 31681909 [PubMed]

PMCID: PMC6824723

EC Microbiology
Molecular Detection of Leptospira spp. in Rodents Trapped in the Mozambique Island City, Nampula Province, Mozambique.

PMID: 31681910 [PubMed]

PMCID: PMC6824726

EC Neurology
Endoplasmic Reticulum-Mitochondrial Cross-Talk in Neurodegenerative and Eye Diseases.

PMID: 31528859 [PubMed]

PMCID: PMC6746603

EC Psychology and Psychiatry
Can Chronic Consumption of Caffeine by Increasing D2/D3 Receptors Offer Benefit to Carriers of the DRD2 A1 Allele in Cocaine Abuse?

PMID: 31276119 [PubMed]

PMCID: PMC6604646

EC Anaesthesia
Real Time Locating Systems and sustainability of Perioperative Efficiency of Anesthesiologists.

PMID: 31406965 [PubMed]

PMCID: PMC6690616

EC Pharmacology and Toxicology
A Pilot STEM Curriculum Designed to Teach High School Students Concepts in Biochemical Engineering and Pharmacology.

PMID: 31517314 [PubMed]

PMCID: PMC6741290

EC Pharmacology and Toxicology
Toxic Mechanisms Underlying Motor Activity Changes Induced by a Mixture of Lead, Arsenic and Manganese.

PMID: 31633124 [PubMed]

PMCID: PMC6800226

EC Neurology
Research Volunteers' Attitudes Toward Chronic Fatigue Syndrome and Myalgic Encephalomyelitis.

PMID: 29662969 [PubMed]

PMCID: PMC5898812

EC Pharmacology and Toxicology
Hyperbaric Oxygen Therapy for Alzheimer's Disease.

PMID: 30215058 [PubMed]

PMCID: PMC6133268

News and Events

May Issue Release

We always feel pleasure to share our updates with you all. Here, notifying you that we have successfully released the May issue of respective journals and the latest articles can be viewed on the current issue pages.

Submission Deadline for Upcoming Issue

ECronicon delightfully welcomes all the authors around the globe for effective collaboration with an article submission for the upcoming issue of respective journals. Submissions are accepted on/before May 25, 2022.

Certificate of Publication

ECronicon honors with a "Publication Certificate" to the corresponding author by including the names of co-authors as a token of appreciation for publishing the work with our respective journals.

Best Article of the Issue

Editors of respective journals will always be very much interested in electing one Best Article after each issue release. The authors of the selected article will be honored with a "Best Article of the Issue" certificate.

Certifying for Review

ECronicon certifies the Editors for their first review done towards the assigned article of the respective journals.

Latest Articles

The latest articles will be updated immediately on the articles in press page of the respective journals.